• Headquarters: Granules India is headquartered in Hyderabad, India, and has a global presence.
• Vertical Integration: It is a vertically integrated pharmaceutical company with over 40 years of proven performance.
• Product Range: Granules India manufactures high-quality API (Active Pharmaceutical Ingredients), FD (Finished Dosage), and PFI (Pharmaceutical Formulation Intermediates).
• Customer-Centric Approach: The company focuses on collaborative and strategic partnerships with global pharmaceutical leaders.

The Illustrious Journey

From its origins as a paracetamol API manufacturing facility, Granules India has evolved into a multi-faceted global player. Here are some highlights:

• Quality Standards: Granules consistently achieves manufacturing success and sets new standards of quality.
• Global Footprint: With 10 manufacturing facilities and a presence in 80+ countries, Granules India continues to expand its reach.
• Recent Achievements:
  • USFDA Approval: Granules India recently received USFDA approval for its generic Glycopyrrolate oral solution.
  • Depression Treatment: The company’s generic formulation to treat depression also gained USFDA approval.
  • Empowering Women: Priyanka Chigurupati, a leader at Granules, advocates for inclusivity in the health industry.

Location in JNPC

• Address: Jawaharlal Nehru Pharmacity, Paravada, Visakhapatnam, Andhra Pradesh 531021, India.
• For more details, you can visit the Granules India website.

Granules India’s commitment to excellence, innovation, and global impact makes it a significant contributor to the pharmaceutical landscape. ??

Feel free to ask if you’d like additional information! ??